These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 23128517

  • 1. Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.
    Rooke C, McNeill A, Arnott D.
    Nicotine Tob Res; 2013 Jun; 15(6):1052-9. PubMed ID: 23128517
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT, Abrams DB.
    BMC Public Health; 2016 May 24; 16():432. PubMed ID: 27221096
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J.
    Yale J Health Policy Law Ethics; 2013 May 24; 13(2):326-74. PubMed ID: 24340824
    [Abstract] [Full Text] [Related]

  • 11. Tobacco harm reduction: what do the experts think?
    Martin EG, Warner KE, Lantz PM.
    Tob Control; 2004 Jun 24; 13(2):123-8. PubMed ID: 15175526
    [Abstract] [Full Text] [Related]

  • 12. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL.
    Ann Am Thorac Soc; 2014 Feb 24; 11(2):231-5. PubMed ID: 24575992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT.
    Am J Prev Med; 2007 Dec 24; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [Abstract] [Full Text] [Related]

  • 15. Tobacco harm reduction: the need for new products that can compete with cigarettes.
    Fagerström KO, Bridgman K.
    Addict Behav; 2014 Mar 24; 39(3):507-11. PubMed ID: 24290207
    [Abstract] [Full Text] [Related]

  • 16. The place for harm reduction and product regulation in UK tobacco control policy.
    Gilmore AB, Britton J, Arnott D, Ashcroft R, Jarvis MJ.
    J Public Health (Oxf); 2009 Mar 24; 31(1):3-10. PubMed ID: 19109341
    [Abstract] [Full Text] [Related]

  • 17. Harm reduction policies for tobacco users.
    Gartner C, Hall W.
    Int J Drug Policy; 2010 Mar 24; 21(2):129-30. PubMed ID: 19944582
    [Abstract] [Full Text] [Related]

  • 18. Permissive nicotine regulation as a complement to traditional tobacco control.
    Sumner W.
    BMC Public Health; 2005 Feb 24; 5():18. PubMed ID: 15730554
    [Abstract] [Full Text] [Related]

  • 19. Philip Morris research on precursors to the modern e-cigarette since 1990.
    Dutra LM, Grana R, Glantz SA.
    Tob Control; 2017 Dec 24; 26(e2):e97-e105. PubMed ID: 27852893
    [Abstract] [Full Text] [Related]

  • 20. Nicotine regulation and tobacco harm reduction in the UK.
    Britton J, McNeill A.
    Lancet; 2013 Jun 01; 381(9881):1879-80. PubMed ID: 23725716
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.